Kapadia Sandip 4
4 · Harmony Biosciences Holdings, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-09-30+45,000→ 45,000 total - Exercise/Conversion
Restricted Stock Units
2025-09-30−45,000→ 45,000 total→ Common Stock (45,000 underlying) - Tax Payment
Common Stock
2025-09-30$27.56/sh−24,039$662,515→ 20,961 total
Footnotes (2)
- [F1]Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
- [F2]The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.